{"disease":{"id":"polymyalgia-rheumatica","name":"Polymyalgia rheumatica","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":3,"pipeline_drug_count":0,"trial_count":3},"drugs":{"marketed":[{"drug_id":"sarilumab","indication_name":"Polymyalgia Rheumatica","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SARILUMAB","company_name":"","drug_phase":"marketed","molecular_target":"IL-6 receptors (sIL-6R and mIL-6R)","drug_class":"Interleukin-6 Receptor Antagonist [EPC]","quality_score":60,"revenue":null,"mechanism":"Sarilumab inhibits IL-6 signaling by binding to both soluble and membrane-bound IL-6 receptors."},{"drug_id":"intra-articular-corticosteroid-injections","indication_name":"Polymyalgia rheumatica","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Intra-articular corticosteroid injections","generic_name":"intra-articular-corticosteroid-injections","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"prednisolone","indication_name":"Polymyalgia rheumatica","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prelone","generic_name":"prednisolone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"Glucocorticoid (corticosteroid)","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"prednisolon","indication_name":"Polymyalgia rheumatica","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"prednisolon","company_name":"Hannover Medical School","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, G-protein coupled bile acid receptor 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04239521","title":"The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata","phase":"","overall_status":"COMPLETED","enrollment_count":51955,"lead_sponsor_name":"Momentum Data","has_results":false},{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT06766552","title":"A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04402086","title":"Rheumatology Patient Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT04102930","title":"Clinical and Immunogenetic Characterization of Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)","phase":"","overall_status":"RECRUITING","enrollment_count":4500,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT05935709","title":"DANIsh VASculitis Database (DANIVAS)","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Aarhus University Hospital","has_results":false},{"nct_id":"NCT06011512","title":"Risk of Diabetes Mellitus in Patients With Giant Cell Arthritis and Polymyalgia Rheumatica.","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Salome Kristensen","has_results":false},{"nct_id":"NCT07132164","title":"Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":400,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05767034","title":"Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":381,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04664465","title":"PRediction of DIverse Glucocorticoids ToxIcity OUtcomeS","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT07286214","title":"Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT05435781","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Marianne Christina Klose","has_results":false},{"nct_id":"NCT06763783","title":"Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":240,"lead_sponsor_name":"Region Skane","has_results":false},{"nct_id":"NCT04972968","title":"A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":181,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT06331312","title":"Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":161,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07010484","title":"Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica","phase":"","overall_status":"RECRUITING","enrollment_count":149,"lead_sponsor_name":"Kresten Krarup Keller","has_results":false},{"nct_id":"NCT07279688","title":"Justification And Evaluation of Baricitinib Plus Corticosteroids Versus corticosteroiDs Alone in pOlymyalgia RhEumatica","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT05542316","title":"Validation of the PMR Activity Score and Evolution of Patient-reported Outcomes in Patients With Polymyalgia Rheumatica","phase":"","overall_status":"COMPLETED","enrollment_count":133,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT03600818","title":"Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia Rheumatica","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":118,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT03941184","title":"Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity","phase":"","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05533125","title":"Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica Patients Recently Diagnosed","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Sint Maartenskliniek","has_results":false},{"nct_id":"NCT02908217","title":"Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":113,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06460142","title":"Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"University of Bonn","has_results":false},{"nct_id":"NCT06172361","title":"Induction and Tapering Therapy With Tofacitinib and Glucocorticoid in Patients With Polymyalgia Rheumatica","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":98,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT04519580","title":"Improved Diagnostics and Monitoring of Polymyalgia Rheumatica","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":98,"lead_sponsor_name":"Kresten Krarup Keller","has_results":false},{"nct_id":"NCT03576794","title":"Treatment With Leflunomide in Patients With Polymyalgia Rheumatica","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":94,"lead_sponsor_name":"Elisabeth Brouwer","has_results":false},{"nct_id":"NCT05436652","title":"A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Sparrow Pharmaceuticals","has_results":false},{"nct_id":"NCT06130540","title":"Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03263715","title":"A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":39,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT03632187","title":"Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":34,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT06647134","title":"A Qualitative Assessment of the Severity and Impact of Rheumatic Immune-Related Adverse Events Following Immune Checkpoint Inhibitor Immunotherapy","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04727879","title":"Immunopathology of Polymyalgia Rheumatica on Shoulder Bursae's Biopsies","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT01364389","title":"A 3-arm Proof of Concept Study of AIN457, ACZ885 or Corticosteroids in Patients With Polymyalgia Rheumatica","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":16,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04062006","title":"Low-dose Interleukin-2 Treatment on Polymyalgia Rheumatica","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05312944","title":"Polymyalgia Rheumatica Associated to Primary Sjogren Syndrome","phase":"","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04799262","title":"Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT07394478","title":"Study of the Association Between Sacroiliitis/Axial Spondylarthritis and Giant Cell Arteritis/ Polymyalgia Rheumatica","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Hôpital NOVO","has_results":false},{"nct_id":"NCT05681676","title":"Melanocortin Gene Expression in Lymphocytes of Polymyalgia Patients","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Aalborg University","has_results":false},{"nct_id":"NCT03656627","title":"Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Alliance Foundation Trials, LLC.","has_results":false},{"nct_id":"NCT06281236","title":"A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Sparrow Pharmaceuticals","has_results":false},{"nct_id":"NCT02899026","title":"Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":41},"guidelines":[],"source":"Drug Landscape verified database"}